February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 12, 2025

Fluoroquinolones vs Amoxicillin: Anaphylaxis Risk

Moxifloxacin carries the highest anaphylaxis risk among fluoroquinolones, while the entire drug class shows a lower risk than amoxicillin, Penn State researchers reported.

Conexiant

February 10, 2025

Cleaning Product Use May Heighten Asthma Risk

Researchers find persistent weekly use of multiple disinfectants and cleaning products over 10 years shows potential association with increased asthma risk, though study notes significant uncertainty in findings.

Conexiant

February 05, 2025

FDA Approves Tocilizumab Biosimilar

FDA approves AVTOZMA after phase III trial confirms equivalence in efficacy, safety, and pharmacokinetics for RA and other inflammatory conditions.

Conexiant

February 04, 2025

FDA Approves Clinical Trials for Genetically Modified Pig Kidney Transplants

FDA-cleared clinical trials will assess the safety, immunogenicity, and viability of genetically modified pig kidney transplants in patients with end-stage renal disease.

Conexiant

February 03, 2025

Hypoxia Pathway Key in Asthma-COPD Overlap

Researchers highlighted distinct inflammatory profiles, lung function decline, and structural changes associated with asthma-COPD overlap compared to asthma and COPD.

Conexiant